Overview

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and perform preliminary clinical evaluation in patients with mild to moderate CDAD.
Phase:
Phase 2
Details
Lead Sponsor:
Optimer Pharmaceuticals LLC